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Abstract
Recombinant monoclonal antibodies are established by screening the antibody libraries. 
To obtain antibodies with a high specificity and affinity, an efficient screening process 
with a highly diverse library including low background signals is necessary. One of the 
most extensively used methods is the phage display method. Although phage display 
screening is a powerful tool for enriching clones from vast libraries, it is not easy to iden-
tify single clones with an antigen recognition function only through several rounds of 
biopanning. The application of colony assays for screening antibody libraries can identify 
clones with a high reliability by a direct observation of the antibody-antigen binding 
during the screening process; however, the size of the library that can be dealt with is 
limited. This chapter describes the colony assay as a current screening technology used 
in recombinant monoclonal antibody production, the possible problems in this method, 
and discusses the outlook for this technology.
Keywords: colony assay, screening, antibody library, scFv, E. coli, phage display
1. Introduction
The use of recombinant technology for antibody selection offers several advantages over 
conventional antibody selection strategies, such as the selection of antibodies against toxic 
or non-immunogenic antigens unattainable using conventional methods [1, 2], the ability to 
select positive clones from vast libraries [3], the realization of in vitro screening [4], and the 
bypass of animal usage [5]. The selection and production of recombinant monoclonal anti-
bodies require the creation of highly diverse libraries [6] and the subsequent identification 
of positive clones using a screening technology with low background signals [7]. In partic-
ular, the variable domains of the antibody heavy and light chain (V
H
 and V
L
) are isolated 
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from the lymph tissue of immunized animals and linked together for creating a single-chain 
variable fragment (scFv) library, and Fab libraries are constructed too. In general, the anti-
body fragments used for screening are the scFvs. Currently, entirely synthetic libraries [8–11] 
and naïve libraries [12] are being used. These antibody gene libraries are incorporated into 
a phagemid or plasmid and expressed in phage or Escherichia coli (E. coli). Further, panning 
[13] or colony assays [14] are performed to isolate scFvs possessing affinity to the antigen, 
thereby establishing monoclonal antibodies. This step, the screening of antibody libraries, is 
critical for establishing monoclonal antibody fragments with a high affinity and specificity 
against the antigen. One of the most extensively used methods is the phage display method 
[15, 16]. The display of the antibody repertoires on the surface of bacteriophages and their 
selection through panning enables the isolation of monoclonal antibodies [17]. Phage display 
is also widely used for affinity maturation [18, 19], in which mutations are introduced into 
the variable domains of an antibody gene mainly into CDRs to produce antibodies with a 
higher affinity as the original clone [20]. In addition, cell surface panning techniques [1, 21, 22] 
are being developed to establish antibodies recognizing membrane proteins on living cells 
that are difficult to produce using the conventional methods. Technologies that enable liq-
uid panning rather than immobilizing the antigens to a solid phase have also been proposed 
for phage display to establish antibodies that recognize protein conformation [23]. Screening 
with a colony assay induces the actual expression of the scFvs themselves and involves a 
direct confirmation of the antigen-antibody binding, lending it the advantage of a low false-
positive rate. In addition, the method can be easily used to screen libraries in the order of 
magnitude larger than those that can be screened with the hybridoma technology. However, 
this method poses several problems: it requires extensive and complex manipulation of assay 
steps, the expression of antibody fragments could be at times nonexistent or very low, and 
the extensive manipulation during the assay can lead to contamination and death of the 
E. coli cells, potentially preventing gene retrieval. Although this technique is not complete and 
not widely applied, further development and improvement can render it highly beneficial.
2. Antibody library screening
A critical step in the establishment of antigen-specific monoclonal antibody fragment clones is 
the screening of the recombinant-antibody libraries [6, 7]. Methods for screening the antibody 
libraries can be largely divided into two strategies [24]: the display and repertoire cloning 
strategies (Figure 1).
2.1. Display strategies for antibody library screening
In the display strategy [25], the antibody fragment and its gene, i.e., the antigen recogni-
tion function and information, are joined, and antibody fragments with an affinity against 
the antigen are screened. Phage display systems in which an scFv joined to the filamentous 
phage coat protein, g3p, is displayed on the phage are extensively used [15, 16]. Other display 
systems include yeast display systems in which scFvs are displayed on the surface of yeast 
[26]; mRNA display [27]; ribosome display in which a ribosome, mRNA, and an scFv are 
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integrated [28]; bacterial surface display [29]; and mammalian cell surface display [30, 31] for 
human antibody discovery. In these display systems, panning is applied for screening [13]. 
The antigen is immobilized on the surface of a microtiter plate, and the scFv library can be 
screened with phage display and with ribosome/mRNA display. Weakly bound clones are 
removed by washing, retaining the specific clones bound to the antigen (Figure 1A). This 
panning method is characterized by repeated selection, proliferation, and the enrichment of 
positive clones for enabling the processing of large libraries. For yeast, bacterial and mamma-
lian cell surface display FACS with the cells displaying the recombinant antibody fragments 
using labeled antigen is applied.
2.2. Repertoire cloning strategies for antibody library screening
In contrast, in repertoire cloning strategies, the antibody library is transformed into E. coli; 
the scFvs are expressed and secreted from a single clone, and scFvs are screened by ELISA 
(Figure 1B). Clones are selected based on assays, using scFv characteristics such as the affin-
ity; thereby, this method offers advantages such as low false-positive rates and the ability to 
reliably identify clones with a high affinity. However, an assay must be performed for each 
individual E. coli clone, and only the positive clones are selected. There is no enrichment pro-
cess in the screening method, and only limited libraries can be used for antibody selection.
Particularly, antibody repertoires from immunized animals with a clone number of approxi-
mately 106 are suitable for the repertoire cloning but not naïve and synthetic antibody 
Figure 1. Strategies for antibody library screening. (A) Display strategy: scheme of the phage display panning process. 
(B) Repertoire cloning strategy: scheme of the cloning and assay process. (C) Detection of antigen-specific antibody 
fragments released from a bacterial colony by a colony assay.
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repertoires with high clone numbers (109–1012 clones). During the assay, a clone from an 
 E. coli library is cultured, and its expression is induced. The reactivity of the expressed scFv 
against the antigen is measured. Clones exhibiting high reactivity are selected as the posi-
tive clones. In this method, only a few thousands of clones can be examined simultaneously, 
even if a multi-well microtiter plate is used. Although this number is higher than the clones 
obtained by the hybridoma technique, positive clones cannot be efficiently obtained, when 
the positive ratio is low.
Colony assay in which periplasmic expression and E. coli colony formation lifted onto filters 
are used provides a method for handling large libraries (Figure 1C). In colony assay, the 
clones do not need to be picked up individually before screening; all the colonies on the 
plate can be assayed simultaneously. Thus, numerous clones can be assayed from a single 
plate. Antibody fragments released by bacteria were detected by a phage plaque assay in ear-
lier experiments [32, 33]. Libraries of the antibody fragments were expressed in E. coli using 
phage λ vectors [34, 35]. Then, the active fragments secreted from the viable E. coli colonies 
were detected by colony-lift immunoassay [36]. With the colony assay, considerably larger 
libraries can be dealt with because the number of colonies screened can be easily increased.
2.3. Screening with a phage display
In a phage display system, panning is used to isolate phages that display the antibody frag-
ments exhibiting affinity to the antigen (Figure 1A). Positive clones are established by select-
ing only the phages that displays antibody fragments (primarily scFvs) fused to the g3p coat 
proteins on the surface of the filamentous phage, which have affinity to the antigen. This 
method has the advantage of processing large libraries (~1011) [3, 37]. The antigen is immobi-
lized, and the recombinant phage bound to the antigen is left intact; weakly bound recombi-
nant phages are washed away. The remaining recombinant phages, which possess a binding 
capacity are detached from the antigen by acid treatment and infected into E. coli. Further, 
E. coli cells are cultured to propagate positive clones. The E. coli clones expressing the phage-
mids are then infected with a helper phage, and the phages displaying scFvs with binding 
capacities are collected. Panning is performed repeatedly for the selected group of phages. 
The repeated selection and propagation of positive clones enrich clones with antibodies com-
prising binding capacities to the antigen. Then, single clones are isolated at the final step with 
high binding capacities [38]. This method renders it possible to handle large libraries.
One limitation of this method is that the high background during panning selection often 
results in false-positive clones. A specific antigen-binding activity is typically not the only 
driving force exploited during the panning process [39, 40]. Multiple rounds of panning have 
been documented to frequently cause a strong bias for antibodies directed against immuno-
dominant epitopes and abundant proteins [41], resulting in the loss of the library’s diversity 
and of valuable antibody clones. Several factors influence the selection of the antigen-specific 
clones and produce undesired effects; these factors include a high efficiency of expression and 
folding despite poor antigen-binding activity, the nonspecific hydrophobic binding proper-
ties of the phage particle itself, and a superior compatibility with the host cells, not related to 
the antibody fragment affinity.
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However, as several antibody fragments are themselves toxic to E. coli, these clones will be 
lost during panning, even if they possess a high affinity. Conversely, repeated panning may 
result in the relatively preferential propagation of clones with reduced E. coli toxicity, even 
if the clones do not possess a high binding capacity. Toxicity to E. coli can increase the back-
ground, resulting in several false-positive clones being obtained. This situation renders pan-
ning extremely difficult; it is not easy to establish single positive clones only through several 
rounds of panning [14]. Although the phage display is a powerful tool for establishing mono-
clonal antibodies, it is used less frequently than expected [39].
3. Colony assay for antibody library screening
As an alternative antibody-screening tool, the colony assay can be used which is sometimes 
superior to the phage display method [42]. The advantage of this method is that the antibody-
antigen binding can be directly observed during the screening process, reducing the selection 
of false-negative clones [24]. Thus, the colony assay presents notable advantages over the 
phage display and biopanning method.
3.1. Principle of the colony assay
In the colony assay (Figure 2), antibody libraries are expressed in E. coli for the selection of 
clones with a favorable affinity to the antigen. An scFv library is transformed into E. coli cells, 
and afterward transformed E. coli cells are plated on appropriate agar plates. After growing 
of the colonies, they are lifted onto a filter. Further, an expression-inducing reagent such as 
isopropyl-β-D-thiogalactopyranoside (IPTG) is applied, inducing the expression and secre-tion of scFvs from the E. coli cells (Figure 2A). scFvs with the desired affinity will diffuse out 
and bind the antigen coated on the membrane beneath the colonies. However, scFvs without 
affinity will not bind the antigen (Figure 2B), and the unbound scFvs are washed away. Then, 
the bound scFvs with an affinity against the antigen are detected using an enzymatic method. 
The His-tags attached to the scFvs are detected with anti-His antibodies (Figure 2C). Positive 
clones are identified as the colonies corresponding to positive signals (Figure 2D).
3.2. Filter-sandwich assay
Dreher et al. [43, 44] improved the colony assay by developing the filter-sandwich colony-
screening assay (hereafter, the filter-sandwich assay) for selecting positive clones; E. coli colo-
nies are grown directly on a hydrophilic filter, which is then transferred to an antigen-coated 
membrane soaked with IPTG solution and placed on an agar plate containing IPTG to induce 
antibody fragment production. The antibody fragments produced by the colonies diffuse out 
and bind to the antigen on the membrane. The presence of antibody fragments bound to the 
membrane is then detected, and the spot is superimposed on the colony. This method cir-
cumvents the difficult technique of lifting the colony [14, 36]. In addition, the filter-sandwich 
assay was further optimized. The procedure can now be performed by a single step [45] under 
tightly controlled IPTG concentration for expression of the scFvs.
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3.3. Procedure for filter-sandwich assay
The procedure used in the filter-sandwich colony assay is depicted schematically in Figure 3.
In particular, the RNAs are isolated from the lymph tissue of immunized animals, and the 
corresponding cDNA is synthesized; this cDNA is used as the template for the polymerase 
chain reaction (PCR) amplification of the V
L
 and V
H
 domains. Further, the variable domains 
are assembled to an scFv and cloned into an expression vector to create the scFv libraries 
[46]. As expression vector, for example, pET22b (+), containing a pelB signal sequence for 
periplasm expression and a His-tag sequence for the detection of the scFv expression driven 
by the T7 promoter, is used. The antibody repertoire is transformed into E. coli, and the filter 
sandwich assay is performed as described in Figure 3.
The hydrophilic PVDF filter is placed on an agar plate. Transformed E. coli with the scFv 
libraries is spread onto the filter and incubated. After the formation of the bacterial colonies on 
the filter surface, the filter harboring the colonies is transferred to an antigen-coated nitrocel-
lulose membrane on the agar plate containing IPTG and incubated to induce scFv expression. 
Figure 2. Scheme of the colony assay principle. (A) scFvs are expressed and secreted from E. coli. (B) scFvs with the 
desired affinity bind the antigen beneath the colonies. (C) Bound scFvs with an affinity against the antigen are detected 
using an enzymatic method. (D) Positive clones are identified as the colonies corresponding to positive signals.
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Then, the filter harboring the colonies is removed, placed on a fresh plate, and stored for the 
later recovery of the bacteria. Subsequently, antigen-bound scFvs on the nitrocellulose mem-
brane are detected with chemiluminescence from a horseradish peroxidase (HRP)-conjugated 
anti-His antibody. The filter harboring the colonies and the image presenting the chemilumi-
nescence data are superimposed, and positive colonies corresponding to the chemilumines-
cence signals are identified. These positive clones are transferred to a medium and incubated. 
The plasmid encoding the scFv gene with an affinity against the antigen is purified, and the 
antibody coding sequence is determined.
3.4. Establishing monoclonal antibody fragments by colony assay
A colony assay is used for screening the antibody fragments against a variety of antigens, with 
optimizations for each specific purpose. The recombinant antibody fragments against EspA 
and the intimin of E. coli O157:H7 were established by colony filter screening [47]. Colony-lift 
assay was combined with phage display, using cell-coated filters to screen the phage librar-
ies for cell-binding clones [48]. Robert et al. developed subtractive colony filter screening to 
select scFvs that recognize atherosclerotic but not the normal aorta [49]. Giovannoni et al. 
Figure 3. Procedure for filter-sandwich colony assay.
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isolated antiangiogenesis antibodies from combinatorial libraries by iterative colony filter 
screening: colonies located around the positive signals were selected, and the screening step was 
repeated; monoclonal scFvs were established after several rounds of the assay [50]. Neumann-
Schaal et al. developed a colony-screening method in which E. coli colonies producing the 
required scFv were selected in the presence of ampicillin conjugated to the antigen of interest; 
this method relies on the neutralization of the conjugate by the produced scFv. The scFvs were 
identified against biotin by the growth of the scFv library-expressing E. coli in the presence of 
a biotin-ampicillin conjugate [51]. Kumada et al. improved the sensitivity of the colony assay 
utilizing antibody-coupled liposome encapsulating HRP [52].
4. Summary
It is possible to screen 3–5 × 103 clones on a 10-cm diameter plate in a filter-sandwich assay, 
whereas in the hybridoma method, dozens of 96-well microtiter plates are required for screen-
ing these clones. Further, the filter-sandwich assay can be readily upscaled by increasing the 
number of plates. Therefore, the number of positive clones from the filter-sandwich assay can 
be higher than that from the hybridoma method. This would increase the chance of obtaining 
monoclonal antibody fragments with the desired affinity, specificity, and function.
However, the filter-sandwich assay needs to be improved further for the selection of positive 
clones, particularly with respect to the reliability of the antibody fragment expression and the 
handling of the colonies during the assay. For the colony assay, the control of the expression 
level is critical. Because the scFv expression by itself is considerably toxic to E. coli, an excess 
induction of expression, namely, exposure to an excess of the expression-inducing reagent 
(IPTG), leads to cell death and prevents the selection of antigen-specific scFvs. Conversely, 
exposure to insufficient IPTG induces inadequate antibody expression for the detection of 
signals from positive clones. In the filter-sandwich assay, expression induction is not strin-
gently controlled because the concentration of the IPTG added to the cells cannot be precisely 
controlled. IPTG reaches the colonies by diffusing through the filter from the antigen-coated 
membrane and the agar plate. Quantitative control of the expression level is required for 
superior screening. This uncertainty in the IPTG concentration in the filter-sandwich assay 
also causes a problem in the induction timing. For appropriate induction, the colony size is 
a critical factor [14, 44]; however, the colony continues to grow during the assay. Hence, the 
timing of the expression induction is crucial for proper expression. If the ITPG diffusion is 
delayed, an initially small colony would grow too large for proper induction to occur; how-
ever, if the colonies are too small, the signal from each colony is inadequate for detecting the 
antigen binding. The induction strength cannot be accurately determined, particularly dur-
ing the step, when the filter is transferred to the IPTG-containing plate to initiate the induc-
tion of expression. These induction-related uncertainties in the filter-sandwich assay lead to 
unstable expression and failure in isolating the antibody-encoding genes. Stringent control 
of the expression level is critical. Various factors related to the expression vector, such as the 
promoter, strength of the ribosomal binding site, fusion tags, and the copy number, must be 
optimized [53–57]. The incubation temperature is also an important factor in controlling the 
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expression strength [58]. For inducing expression, additional methods such as the cold-shock 
system [59] should be examined. Expression-inducing reagents that are less toxic than IPTG 
to E. coli, such as rhamnose [60], should also be tested.
In the filter-sandwich assay, before the induction of antibody expression, the filter harboring 
the colonies must be transferred without disturbance. This transfer requires delicate manipu-
lation of the filter and frequently produces unwanted stress on the filter, occasionally disturb-
ing the colonies themselves. A method that does not require the transfer of the filter should be 
developed for more efficient antibody establishment. Recently, a single-step colony assay was 
established by us using a tightly controlled IPTG concentration for scFv expression [45]. One 
advantage is also that no transfer of the filter on which the colonies are grown to the antigen-
coated membrane is necessary.
The establishment of a high-quality antibody library and efficient screening are the most impor-
tant factors for successful recombinant antibody selection and production. Improvements in the 
screening technology are critical for quickly and reliably establishment of high-performance 
antibodies. Phage display screening is a powerful tool for this purpose; however, it has certain 
disadvantages such as the frequent selection of false-positive clones, but it can easily deal with a 
vast library. On the other hand, screening with a colony assay could identify the positive clones 
reliably; however, it cannot deal with a large complex library. Thus, screening methods using a 
display panning system and a colony assay have certain advantages and disadvantages, respec-
tively. They should be utilized cooperatively, depending on the purpose of the experiments. 
Hence, condensing the library by phage display and then cloning the positive clones by colony 
assay would be advantageous. To efficiently establish high-quality antibodies, the adequate 
choice of these technologies and their combination would be crucial.
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